Human cytokine-induced killer cells have enhanced in vitro cytolytic activity via non-viral interleukin-2 gene transfer

Modulation of the immune system by genetically modified immunological effector cells is of potential therapeutic value in the treatment of malignancies. Interleukin-2 (IL-2) is a crucial cytokine which induces potent antitumor response. Cytokine-induced killer cells (CIK) have been described as high...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaraj, Srinivas, Ziske, Carsten, Schmidt-Wolf, Ingo GH
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Short Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516021/
https://www.ncbi.nlm.nih.gov/pubmed/15329148
http://dx.doi.org/10.1186/1479-0556-2-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC516021/
https://www.ncbi.nlm.nih.gov/pubmed/15329148
http://dx.doi.org/10.1186/1479-0556-2-12

Ejemplares similares